Stock Rich List
#795 on the rich list of 14,452 insiders

Mahkam Zanganeh

Co-Chief Executive Officer at Summit Therapeutics; Director at Pulse Biosciences. Based in Miami, Florida.

$236M
in disclosed stock, +$63K (+0.03%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
795th of 14,452
Companies held
2
Largest holding
SMMT, 83.5% of total
Latest SEC filing
Nov 16, 2026
Listed but not counted
$6.07B

What the $236M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Summit Therapeutics SMMT
Common Stock
Through the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee
Reported jointly by 2 insiders; split evenly
12,912,237$10.57$136M57.9%Form 4, Nov 16, 2026
Summit Therapeutics SMMT
Common Stock
Through the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee
Reported jointly by 2 insiders; split evenly
5,099,888$10.57$53.9M22.9%Form 4, Nov 16, 2026
Pulse Biosciences PLSE
Common Stock
Directly725,395$44.41$32.2M13.7%Form 4, Feb 3, 2025
Summit Therapeutics SMMT
Common Stock
Directly531,000$10.57$5.6M2.4%Form 4, Nov 16, 2026
Pulse Biosciences PLSE
Common Stock
Immediate Family Member 3107,074$44.41$4.8M2.0%Form 4, Jan 24, 2025
Pulse Biosciences PLSE
Common Stock
Immediate Family Member 127,000$44.41$1.2M0.5%Form 4, Jan 24, 2025
Summit Therapeutics SMMT
Common Stock
Immediate family member76,680$10.57$811K0.3%Form 4, Nov 16, 2026
Pulse Biosciences PLSE
Common Stock
Immediate Family Member 214,000$44.41$622K0.3%Form 4, Jan 24, 2025

Share counts are the amounts Mahkam Zanganeh reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Mahkam Zanganeh's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Summit Therapeutics SMMT
Common Stock
Through Spouse
Counted on the profile of the insider who holds these shares directly
573,883,879$10.57$6.07B—Form 4, Nov 16, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jun 12, 2026BoughtSMMT3,810,000$13.12$50.0MView
Jun 4, 2026BoughtSMMT100,000$14.60$1.5MView
Oct 21, 2025BoughtSMMT26,680$18.74$500KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
792Firat Ileri
Director, BillionToOne
$236M−$3.5M (−1.46%)
793James E. Douglas III
Insider, IMAX. Greenbrae, CA
$236M−$3.1M (−1.30%)
794Kevin Douglas
Director, IMAX. Greenbrae, CA
$236M−$3.1M (−1.30%)
795Mahkam Zanganeh
Co-Chief Executive Officer, Summit Therapeutics. Miami, FL
$236M+$63K (+0.03%)
796Donald J. Trump Jr.
Director, Trump Media & Technology Group. Coppell, TX
$235M+$2.3M (+0.98%)
797Christopher R. Christensen
Executive Chairman, The Ensign Group. Eagle, ID
$235M−$8.9M (−3.64%)
798Herald Y. Chen
Director, AppLovin. Palo Alto, CA
$235M−$7.3M (−3.02%)

Other Summit Therapeutics insiders

All SMMT insiders

Questions

How much stock does Mahkam Zanganeh own?

Mahkam Zanganeh holds $235,602,097 in listed stock based on SEC filings and current prices, mostly Summit Therapeutics (SMMT). That ranks 795th on the Stock Rich List.

Is this Mahkam Zanganeh's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Mahkam Zanganeh last buy or sell stock?

The most recent open-market trade on file is a purchase of 3,810,000 SMMT shares on Jun 12, 2026 at $13.12.